Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Hoth Therapeutics
Sponsored
content by Hoth Therapeutics
JO
Jolt_Communications
Community Contributor
100% Patient Improvement in trial puts this $16M Biotech on the radar
Key Takeaways Hoth is a clinical-stage biotech with a diversified pipeline across oncology, neurology, and inflammation. Lead drug HT-001 targets cancer treatment related rashes, a multi-hundred-million-dollar niche where no approved therapies exist.
View narrative
US$5.3
FV
65.7% undervalued
intrinsic discount
0%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
2
users have commented on this narrative
118
users have followed this narrative
11 days ago
author updated this narrative
Exxon Mobil
HE
Helzur
Community Contributor
Exxon Mobil's 17.5% Upside Promises Industry-Leading Returns in Energy Transition
This analysis concludes that Exxon Mobil (XOM) represents a compelling investment opportunity, with a fair value of $132.00 per share, implying a 17.5% upside from the current price of $112.32. The BUY recommendation is not based on a speculative bet on higher oil prices, but on the company's fundamental transformation, operational excellence, and disciplined capital allocation that is expected to generate sustainable, industry-leading returns.
View narrative
US$132
FV
14.9% undervalued
intrinsic discount
6.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
15 days ago
author updated this narrative
National HealthCare
DA
DanielGC
Community Contributor
NHC Analysis: Quality at a Good Price. A Golden Opportunity?
Key Takeaways A highly diversified business model and a pristine balance sheet position National HealthCare Corporation for sustained, profitable growth. The company's current low valuation is a result of a short-term drop in net income, which we believe is temporary and creates a compelling investment opportunity.
View narrative
US$179.8
FV
35.4% undervalued
intrinsic discount
18.80%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
1
users have commented on this narrative
23
users have followed this narrative
27 days ago
author updated this narrative
lululemon athletica
AN
AnalystConsensusTarget
Consensus Narrative from 28 Analysts
Product Refresh And Global Expansion Will Empower Future Market Leadership
Key Takeaways Revamped product strategy and agile supply chain processes are set to drive revenue growth and boost conversion in core and international markets. Investments in digital, AI, and omnichannel initiatives aim to enhance customer experience and operational efficiency, supporting long-term demand and margin stability.
View narrative
US$202.6
FV
21.0% undervalued
intrinsic discount
5.24%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
2
users have commented on this narrative
156
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Bentley Systems
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts
Global Infrastructure Investment And Digital Transformation Will Expand Market Opportunities
Key Takeaways Ongoing global infrastructure investment and digital transformation trends are boosting demand for Bentley's advanced AI and cloud solutions, supporting strong revenue and margin growth. Broadening the customer base and rapid adoption of subscription models improve revenue stability, reduce exposure to market cycles, and enhance long-term earnings prospects.
View narrative
US$59.08
FV
10.9% undervalued
intrinsic discount
9.75%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Thermo Fisher Scientific
AN
AnalystHighTarget
Consensus Narrative from 25 Analysts
Aging Populations And Gene Therapies Will Drive Precision Medicine
Key Takeaways Industry-leading innovation, strategic acquisitions, and operational excellence position Thermo Fisher to gain market share and expand margins ahead of competitors as demand for advanced bioprocessing surges. Demographic shifts and rising global demand for cutting-edge healthcare solutions set the stage for sustained earnings growth, broadened market presence, and a widening competitive moat.
View narrative
US$662.17
FV
28.3% undervalued
intrinsic discount
6.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
MarketAxess Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Emerging Markets And Electronic Trading Will Drive Future Success
Key Takeaways Expansion into new markets and digital asset classes is broadening MarketAxess's reach and potential for sustained revenue and earnings growth. Strategic technology investments and regulatory trends are driving increased electronic trading, boosting operating leverage and supporting higher long-term margins.
View narrative
US$218.83
FV
17.0% undervalued
intrinsic discount
7.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
5 days ago
author updated this narrative
Ceragon Networks
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
5G Expansion And Smart City Rollouts Will Fuel Global Connectivity
Key Takeaways Large contract wins and technology leadership position Ceragon for unexpected, rapid growth in recurring high-margin revenues across new markets and industries. Operational discipline, strategic acquisitions, and product innovation support a scalable business model poised for sustained margin and cash flow expansion.
View narrative
US$9
FV
77.4% undervalued
intrinsic discount
-0.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
State Street
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Global Wealth And Passive Investing Will Strengthen Future Asset Servicing
Key Takeaways Growth in assets, fee revenue, and ETF strength positions State Street to capture wealth and retirement flows for sustained expansion. Strategic investments in technology and operational efficiencies are driving cost savings, margin improvement, and deeper client relationships.
View narrative
US$115.61
FV
3.0% undervalued
intrinsic discount
3.35%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
22
users have followed this narrative
5 days ago
author updated this narrative
Agnico Eagle Mines
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Global Uncertainty And Green Trends Will Empower Canadian Mining Operations
Key Takeaways Expansion and technology upgrades may drive production and margin gains beyond expectations, with exploration successes suggesting significant reserve and earnings upside not fully recognized by the market. Strong financial flexibility and top-tier gold asset security position the company for superior shareholder returns and strategic growth opportunities amid industry consolidation and evolving market dynamics.
View narrative
US$207.22
FV
25.8% undervalued
intrinsic discount
9.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
5 days ago
author updated this narrative
Moderna
AN
AnalystLowTarget
Consensus Narrative from 20 Analysts
Inflated Valuation Will Choke Revenue Amid Tighter Global Scrutiny
Key Takeaways Downward pressure on vaccine pricing and growing competition threaten profitability, market share, and long-term revenue stability. Ongoing public skepticism and regulatory scrutiny could restrict demand for mRNA products, slowing diversification and expansion of the product pipeline.
View narrative
US$15
FV
59.2% overvalued
intrinsic discount
-16.41%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Hexatronic Group
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Global 5G And Broadband Expansion Will Fuel Fiber Adoption
Key Takeaways Rapid expansion in data center and harsh environment segments, combined with a strong acquisition pipeline, positions Hexatronic for outsized profit and margin growth ahead of market expectations. Unique vertical integration, global reach, and focus on high-value fiber solutions increase resilience, expand addressable markets, and drive long-term earnings power as digital infrastructure demand accelerates.
View narrative
SEK 30
FV
33.6% undervalued
intrinsic discount
4.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
EVgo
AN
AnalystHighTarget
Consensus Narrative from 10 Analysts
Growing Urban EV Adoption Will Expand Public Fast Charging Opportunities
Key Takeaways Strong capital position and cost advantages support rapid network expansion, improving margins and securing a dominant, defensible share as demand accelerates in urban markets. Proprietary data, AI-driven pricing, and high-speed charger deployment enable superior revenue optimization and utilization, driving operating leverage and long-term growth ahead of rivals.
View narrative
US$11.06
FV
61.2% undervalued
intrinsic discount
39.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies